Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Cisplatin 6Radiotherapy 4Hydralazine 3Gemcitabine 3Valproic Acid 2Probiotics 2Paclitaxel 2Drug Therapy 2Brachytherapy 2spartalizumab 1nimotuzumab 1belotecan 1apatinib 1Therapeutics 1Surgical Procedures, Operative 1Standard of Care 1Radiotherapy, Intensity-Modulated 1Radiation Dose Hypofractionation 1Proto-Oncogene Proteins c-raf 1Neoadjuvant Therapy 1Nelfinavir 1Mobile Health Units 1Magnetic Resonance Spectroscopy 1Magnesium 1Injections 1Immune Checkpoint Inhibitors 1Hysteroscopy 1Heart Rate 1Fatty Acids, Omega-3 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Uterine Cervical Neoplasms × Radiation Dose Hypofractionation × Clear all
NCT03750539 2023-11-14

Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer

National Institute of Cancerología

Phase NA Unknown
100 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡